The IkB kinase complex (IKK) is a key regulator of immune responses, inflammation, cell survival, and tumorigenesis. The prosurvival function of IKK centers on activation of the transcription factor NF-kB, whose target gene products inhibit caspases and prevent prolonged JNK activation. Here, we report that inactivation of the BH3-only protein BAD by IKK independently of NF-kB activation suppresses TNFa-induced apoptosis. TNFa-treated Ikkb À/À mouse embryonic fibroblasts (MEFs) undergo apoptosis significantly faster than MEFs deficient in both RelA and cRel due to lack of inhibition of BAD by IKK. IKK phosphorylates BAD at serine-26 (Ser26) and primes it for inactivation. Elimination of Ser26 phosphorylation promotes BAD proapoptotic activity, thereby accelerating TNFainduced apoptosis in cultured cells and increasing mortality in animals. Our results reveal that IKK inhibits TNFa-induced apoptosis through two distinct but cooperative mechanisms: activation of the survival factor NF-kB and inactivation of the proapoptotic BH3-only BAD protein.
INTRODUCTION
The IkB kinase complex (IKK) plays a central role in immune responses, inflammation, cell survival, and tumorigenesis (Baldwin, 2012; Ghosh and Karin, 2002; Karin and Ben-Neriah, 2000; Liu et al., 2012) . IKK has two catalytic subunits, IKKa and IKKb, and two regulatory subunits, NEMO/IKKg and ELKS (Ghosh and Karin, 2002) . IKK is activated by a variety of extracellular stimuli, including inflammatory cytokines such as tumor necrosis factor (TNFa) (Baldwin, 2012; Liu et al., 2012) . Once activated, IKK phosphorylates IkBs, which are a group of cytoplasmic inhibitors of NF-kB, on specific serines (Ser32 and Ser36 in IkBa and Ser19 and Ser21 in IkBb), triggering their ubiquitination and subsequent degradation by the 26S proteasome (Karin and Ben-Neriah, 2000) . This frees NF-kB dimers to translocate into the nucleus, where they stimulate transcription of the target genes involved in immune responses, inflammation, viral infection, cell survival, and tumorigenesis (Baldwin, 2012; Ghosh and Karin, 2002; Karin and Ben-Neriah, 2000; Liu et al., 2012) . In addition to IkB proteins, IKK has several other substrates, including A20, BCL-10, CYLD, FOXO3a, histone H3, p85a, and RelA, which are involved in NF-kB activation or regulation of autophagy, allergy, immunity, and tumorigenesis (Anest et al., 2003; Comb et al., 2012; Hu et al., 2004; Hutti et al., 2007; Sakurai et al., 1999; Reiley et al., 2005; Wegener et al., 2006) .
The prevailing paradigm of how IKK regulates TNFa-induced apoptosis is the ''NF-kB activation'' model, in which the target gene products of NF-kB inhibit caspases and prevent prolonged JNK activation (Karin and Lin, 2002; Liu et al., 1996 Liu et al., , 2004 Liu and Lin, 2007; Tang et al., 2001 Tang et al., , 2002 Wang et al., 1996a; Van Antwerp et al., 1996) . Genetic disruption of RelA alleles-which are the major transactivating subunit of NF-kB in response to TNFa-in mice results in embryonic lethality with massive apoptosis of hepatocytes in the liver (Beg et al., 1995) . The embryonic lethality can be rescued by inactivation of TNF receptor 1 (TNF-R1), demonstrating that RelA/NF-kB is necessary for cell survival upon TNFa stimulation (Alcamo et al., 2001) . Genetic disruption of IKKb or NEMO/IKKg, but not IKKa, in mice severely impairs NF-kB activation induced by TNFa and other proinflammatory cytokines like IL-1, and like RelA/ NF-kB deficient mice, IKKb-or NEMO/IKKg-deficient mice also have the embryonic lethality (Li et al., 1999a (Li et al., , 1999b Rudolph et al., 2000) . Although activation of NF-kB by IKK is necessary for inhibition of TNFa-induced apoptosis, it is not clear whether IKK can inhibit TNFa-induced apoptosis independently of NF-kB and, if so, what the molecular mechanism is.
The BH3-only protein BAD is a member of the proapoptotic BCL-2 family and plays a critical role in regulation of the mitochondrial death machinery by extracellular stimuli (Danial and Korsmeyer, 2004; Danial, 2008; Dragovich et al., 1998; Youle and Strasser, 2008) . In the presence of growth and survival factors, BAD is phosphorylated at the ''regulatory serines'' (Ser112, Ser136, and Ser155) in a sequential manner, in which phosphorylation of Ser112 and Ser136 is required for phosphorylation of Ser155 (Danial, 2008; Yaffe, 2002; Youle and Strasser, 2008) . Several protein kinases, including PKA, Raf-1, Akt/PKB, Rsk2, and CaMKII, have been reported to phosphorylate BAD at one or both of these regulatory serines in response to survival signals (Bonni et al., 1999; Datta et al., 1997; del Peso et al., 1997; Harada et al., 1999; Kelekar et al., 1997; Wang et al., 1996b; Zha et al., 1996) . In addition, JNK1 can phosphorylate BAD at Thr201 in response to IL-3 and thereby inhibit the proapoptotic activity of BAD (Yu et al., 2004) . Upon withdrawal of survival factors, BAD is hypophosphorylated and subsequently translocates to mitochondrial membrane, where it binds to and inactivates the antiapoptotic BCL-2 family protein BCL-X L (Danial and Korsmeyer, 2004; Danial, 2008; Youle and Strasser, 2008) . However, the role of BAD in cell death induced by other death stimuli like TNFa is poorly understood. Here, we report that IKK inhibits TNFa-induced apoptosis through phosphorylation and inactivation of BAD independently of NF-kB activation. Thus, IKK inhibits TNFa-induced apoptosis through at least two distinct mechanisms: activation of the survival factor NF-kB and inhibition of the proapoptotic protein BAD.
RESULTS

IKK Is Able to Inhibit TNFa-Induced Apoptosis
Independently of NF-kB Activation We were curious whether IKK can inhibit TNFa-induced apoptosis through an NF-kB-independent mechanism. Although RelA is the major transactivating subunit of NF-kB in response to many extracellular stimuli, including TNFa, cRel has been reported to be able to compensate NF-kB activity in the absence of RelA (Barkett and Gilmore, 1999; Gerondakis et al., 1999; Grossmann et al., 1999 quantitative real-time PCR analysis (Figures S1A and S1B available online) or by luciferase assays using an NF-kB reporter gene ( Figure S1C ). As expected, TNFa induced apoptosis in both Ikkb À/À and RelA À/À /sicRel MEFs, but not in WT fibroblasts, as measured by the cleavage of Casp-3 substrate PARP (Figure 1A) . However, the rate of TNFa-induced apoptosis was significantly faster in Ikkb À/À MEFs than that in RelA À/À /sicRel MEFs; the cleavage of PARP in Ikkb À/À MEFs almost reached to the maximum 5 hr after TNFa stimulation, compared to 9 hr in RelA À/À /sicRel MEFs ( Figure 1A ). Similar results were obtained by Casp-3 activity assays ( Figure 1B ) and apoptotic cell death assays ( Figure 1C ), although both kinds of cells died eventually. However, this could be the result of the cell type difference. To exclude this possibility, we used the approach of siRNA silencing. Knockdown of IKKb by its specific siRNA in RelA À/À /sicRel MEFs significantly accelerated TNFa-induced apoptosis, as measured by PARP cleavage (Figure 1D ), Casp-3 activation ( Figure 1E ), and apoptotic cell death assays ( Figure 1F MEFs ( Figures S1D-S1G ). These data demonstrate that IKK can inhibit TNFa-induced apoptosis through an NF-kB-independent mechanism.
IKK, but Not NF-kB, Suppresses BAD Proapoptotic Activity upon TNFa Stimulation The above observation that Ikkb À/À MEFs died significantly faster than RelA À/À /sicRel MEFs suggests that, in addition to activation of NF-kB, IKK may inactivate a proapoptotic factor or activate another survival factor. To test this hypothesis, we determined whether IKK negatively regulates the BH3-only protein BAD, which is a convergent point for many survival signals (Danial and Korsmeyer, 2004; Danial, 2008; Dragovich et al., 1998; Youle and Strasser, 2008) . We found that silencing of BAD by its specific siRNA significantly reduced TNFa-induced apoptosis in Ikkb À/À MEFs, as measured by PARP cleavage (Figure 2A) . Knockdown of BAD did not affect expression of BCL-X L , which is a prosurvival BCL-2 family protein that antagonizes BAD ( Figure 2A ). By contrast, knockdown of BAD had no detectable effects on TNFa-induced apoptosis in RelA
/sicRel MEFs (Figure 2B) . Similar results were obtained by Casp-3 activity assays ( Figure 2C ). Importantly, when BAD was knocked down, Ikkb
and RelA À/À /sicRel MEFs had similar apoptotic rates ( Figure 2C ). These data indicate that the inability of inactivating BAD resulted in the higher apoptotic death rate in Ikkb À/À MEFs ( To determine whether BAD is involved in TNFa-induced apoptosis in vivo, we used WT and Bad knockout mice. When D-GalN-sensitized mice were injected intraperitoneally with TNFa, WT mice had severe liver damage with massive apoptosis of hepatocytes ( Figure 2E ) and started to die around 6 hr (Figure 2F) . By contrast, Bad À/À mice were much less sensitive to TNFa/D-GalN-induced apoptosis in liver, and the mortality was significantly reduced (Figures 2E and 2F ). These results demonstrate that BAD is involved in TNFa-induced apoptosis in animals.
IKK Is a BAD Kinase
Because IKK inhibits BAD proapoptotic activity upon TNFa stimulation (Figure 2) , we hypothesized that IKK may inhibit BAD through phosphorylation. Immune complex kinase assays showed that TNFa-activated IKK significantly phosphorylated purified GST-BAD fusion proteins ( Figure 3A ). The ability of the IKK complex to phosphorylate GST-BAD was well correlated to its phosphorylation of GST-IkBa ( Figure 3A) , which is an authentic IKK substrate. Knockout of IKKb, which is responsible for suppressing TNFa-induced apoptosis (Ghosh and Karin, 2002) , almost completely abolished phosphorylation of GST-BAD by TNFa-activated IKK, whereas ectopic expression of IKKb in Ikkb À/À MEFs restored the ability of IKK to phosphorylate GST-BAD ( Figure 3B ). Thus, IKKb is not only required for activation of NF-kB but is also involved in phosphorylation of the proapoptotic BAD protein upon TNFa stimulation. To determine whether IKKb can directly phosphorylate BAD, we used constitutively active IKKb(EE), in which Ser177 and Ser181 were replaced by glutamic acids (Mercurio et al., 1997; Zandi et al., 1997) . In vitro kinase assays showed that purified IKKb(EE) significantly phosphorylated GST-BAD, as well as GST-IkBa, but not JNK substrate GST-c-Jun ( Figure 3C ). Two-dimensional tryptic phosphopeptide mapping revealed that GST-BAD phosphorylated by IKK isolated from nonstimulated fibroblasts (basal IKK) contained two phosphopeptides, a and b ( Figure 3D ). When GST-BAD phosphorylated by TNFa-activated IKK was analyzed, the phosphopeptide a was significantly increased, whereas the phosphopeptide b remained unchanged, with the appearance of another minor phosphopeptide c ( Figure 3D ). This suggests that phosphopeptide a, as well as phosphopeptide c, to a much less extent, were specifically phosphorylated by active IKK. Similar results were obtained when IKKb(EE)-phosphorylated GST-BAD was analyzed ( Figure 3D ). Phosphoamino acid analysis revealed that GST-BAD phosphorylated by active IKK, as well as the phosphopeptide a, only contained phosphoserine (PS) (Figure 3E ). Taken together, these results demonstrate that IKKb is a BAD kinase that phosphorylates BAD at serine residue(s).
IKK Is Necessary and Sufficient to Phosphorylate BAD at Ser26 In Vitro and In Vivo To identify IKK-phosphorylated serine residue(s), we constructed a C-terminal truncated GST-DC-BAD(1-114) and an N-terminal truncated GST-DN-BAD(115-204) ( Figure S3A ). Immune complex kinase assays showed that GST-DN-BAD(115-204) was phosphorylated by basal IKK, and the phosphorylation was only slightly increased when active IKK was used ( Figure S3A ). By contrast, phosphorylation of GST-DC-BAD(1-114) was significantly enhanced when TNFa-activated IKK was used , and RelA À/À fibroblasts were transfected with siRNA against cRel (sicRel) or control siRNA (siCtrl) as indicated for 24 hr, followed by stimulation with or without TNFa (5 ng/ml). Cleavage of Casp-3 substrate PARP and expression of RelA, cRel, and IKKb were analyzed by immunoblotting (A), measurement of Casp-3 activity (B), and apoptotic cells, which were identified by Annexin V and PI staining followed by flow cytometric analysis (C).
(D-F) RelA À/À MEFs were transfected with sicRel, along with siIKKb or siCtrl for 24 hr, followed by stimulation with or without TNFa (5 ng/ml). PARP cleavage and expression of IKKb and cRel were analyzed (D). Casp-3 activity (E) and apoptotic cell death (F) were measured as described in (B) and (C), respectively. (G-I) Ikkb À/À MEFs were transfected with siRelA plus sicRel or siCtrl for 24 hr, followed by stimulation with or without TNFa (5 ng/ml). PARP cleavage and expression of RelA and cRel were analyzed (G). Casp-3 activity (H) and apoptotic cell death (I) were measured as in (B) and (C), respectively. The results in (B), (C), (E), (F), (H), and (I) are presented as means ±SE and represent three individual experiments. *p < 0.05 and **p < 0.01, as analyzed by Student's t test. See also Figure S1 .
( Figure S3A ). Two-dimensional phosphopeptide mapping analysis revealed that, in comparison to GST-BAD, GST-DN-BAD contained phosphopeptide b, whereas GST-DC-BAD contained phosphopeptide a (major) and c (minor) ( Figure S3B ). These results indicate that active IKK phosphorylation site(s) are located in the N-terminal half of BAD.
To determine the precise IKK-phosphorylation site(s) on BAD, we systemically replaced all serine residues within the N-terminal half (1-114) in the full-length GST-BAD with nonphosphorylatable alanines either individually or in different combinations, using a site-directed mutagenesis approach ( Figure S3C ). Immune complex kinase assays showed that TNFa-activated IKK was unable to phosphorylate the GST-BAD(S26A) mutant in comparison to WT GST-BAD ( Figure 4A ). Similar results were obtained with purified IKKb(EE) ( Figure 4B ). By contrast, other GST-BAD mutants were still phosphorylated by active IKK ( Figure S3D ). Two-dimensional phosphopeptide mapping revealed that the replacement of Ser26 by Ala resulted in complete elimination of the phosphopeptide a and c but had no effects on phosphopeptide b ( Figure 4C ). Analysis of IKKphosphorylated GST-BAD proteins by tandem mass spectrometry (MS/MS) also revealed that Ser26 was phosphorylated by IKK ( Figure 4D ).
To analyze the regulation of BAD Ser26 phosphorylation in vivo, we generated a rabbit polyclonal antibody using a synthetic BAD phosphopeptide containing phosphorylated Ser26 as an immunogen. Immunoblotting analysis revealed that the anti-phospho-Ser26 antibody specifically recognized active IKK-phosphorylated GST-BAD, but not nonphosphorylated GST-BAD or GST-BAD(S26A) mutant ( Figure 4E ). This was not a result of the difference in the amount of GST-BAD proteins, as analyzed by immunoblotting using anti-GST antibody ( Figure 4E ). Thus, anti-phospho-Ser26 antibody specifically recognizes BAD when it is phosphorylated at Ser26 by IKK.
To determine whether BAD is phosphorylated at Ser26 in response to TNFa in an IKK-dependent manner, we used Ikkb À/À MEFs. Immunoblotting analysis using anti-phosphoSer26 antibody revealed that TNFa rapidly induced BAD phosphorylation at Ser26 in WT, but not in Ikkb À/À MEFs ( Figure 4F ).
Consistently, ectopic expression of WT IKKb in Ikkb À/À MEFs restored BAD phosphorylation at Ser26 in response to TNFa stimulation ( Figure 4G ). Furthermore, ectopic expression of the constitutively active IKKb(EE) alone was sufficient to induce BAD phosphorylation at Ser26 ( Figure 4G ). Interestingly, BAD was also slightly phosphorylated at Ser26 in resting WT fibroblasts ( Figure S3E , longer exposure). This basal level phosphorylation of BAD at Ser26 was completely diminished in Ikkb
MEFs ( Figure S3E , longer exposure), suggesting that IKK is also responsible for BAD basal Ser26 phosphorylation. Taken together, IKK is necessary and sufficient for BAD phosphorylation at Ser26 under both basal and stimulated conditions.
IKK Inhibits the Association between BAD and BCL-X L Independently of NF-kB Activation
We hypothesized that phosphorylation by IKK may promote BAD interaction with 14-3-3, thereby preventing BAD from translocating to the mitochondria to inactivate BCL-X L . To test this idea, we examined the effect of IKKb on the subcellular localization of BAD. TNFa induced apoptotic cell death in Ikkb
, but not in WT fibroblasts, as previously reported (Tang et al., 2001 ; see also Figure 1 ). Immunoblotting analysis revealed that BAD and Ser26-phosphorylated BAD exclusively localized in the cytosolic fractions in TNFa-treated WT fibroblasts ( Figure 5A ). By contrast, a small portion ($3%-6%) of the cytoplasmic BAD, which was not phosphorylated at Ser26, translocated to the mitochondria in TNFa-treated Ikkb À/À MEFs ( Figure 5A ). In fact, a small portion of the cytoplasmic BAD started to translocate to mitochondria as early as 5 min after TNFa stimulation in Ikkb À/À MEFs ( Figure S4A ). These results suggest that IKKb may inhibit mitochondrial translocation of BAD. However, it is possible that translocation of BAD to the mitochondria is the consequence of TNFa-induced apoptosis in Ikkb À/À MEFs. To exclude this possibility, we determined the effect of IKKb on the interaction between BAD and 14-3-3 or BCL-X L . We found that BAD, as well as Ser26-phosphorylated BAD, interacted with 14-3-3 in the cytosol in TNFa-treated WT, but not in Ikkb À/À fibroblasts ( Figure 5B ). Although total cytosolic Ser26-phosphorylated BAD was reduced with time, 14-3-3-associated Ser26-phosphorylated BAD remained unchanged even 3 hr after TNFa stimulation, suggesting that binding with 14-3-3 may inhibit dephosphorylation of Ser26-phosphorylated BAD. Conversely, BCL-X L interacted with BAD in the mitochondrial fractions of TNFa-treated Ikkb
, but not WT fibroblasts ( Figure 5C ). More importantly, only nonphosphorylated, but not Ser26-phosphorylated, BAD was found to associate with BCL-X L at the mitochondria ( Figure 5C ). Immunoprecipitation of BAD from the mitochondria fraction of TNFa-treated Ikkb À/À MEFs also showed that there was no Ser26-phosphorylated BAD ( Figure S4B ). Taken together, these data demonstrate that phosphorylation of BAD by IKK at Ser26 prevents BAD from translocating to the mitochondria to bind to and inactivate BCL-X L , thereby inhibiting the proapoptotic activity of BAD upon TNFa stimulation. , and Ikkb + MEFs, in which Ikkb À/À MEFs were infected with adenoviral vector-encoding HA-IKKb (300 MOI; 24 hr), were stimulated with or without TNFa (5 ng/ml) for 10 min. IKK activity was determined as in (A).
(C) In vitro phosphorylation of purified GST-IkBa, GST-BAD, and GST-c-Jun (5 mg each) by constitutively active IKKb(EE) (24 ng), in which Ser177 and Ser181 were replaced by glutamic acids (EE) and has been purified to near homogeneity.
(D) Phosphorylated GST-BAD proteins were subjected to two-dimensional tryptic phosphopeptide mapping as described (Lin et al., 1992) . Spot b is the major tryptic peptide phosphorylated by basal IKK; spots a and c represent the peptides whose phosphorylation was augmented by active IKK or IKKb(EE).
(E) Phosphorylated BAD or the phosphopeptide a was subjected to phosphoamino acid analysis as described (Lin et al., 1992) . PS, phosphoserine. The data in (A)-(C) represent two to three individual experiments with similar results.
To determine whether inhibition of TNFa-induced BAD mitochondrial translocation by IKK is independent of NF-kB activation, we used RelA À/À MEFs. We found that BAD, as well as Ser26-phosphorylated BAD, associated with 14-3-3 in the cytosolic fractions in both TNFa-treated WT and RelA À/À MEFs, but not in Ikkb À/À MEFs ( Figure 5D ). Consistently, BAD only associated with BCL-X L in the mitochondrial fractions of TNFa-treated Ikkb À/À MEFs, but not WT and RelA À/À MEFs ( Figure 5E ). These data demonstrate that inhibition of BAD by IKK is independent of its activation of NF-kB.
IKK Primes BAD for Its Phosphorylation at the Regulatory Serines
To understand how IKK inhibits BAD mitochondria translocation, we determined its effect on BAD phosphorylation at the regulatory serines. Immunoblotting analysis revealed that phosphorylation of the regulatory serines (Ser112, Ser136, and Ser155) was impaired in Ikkb À/À MEFs upon TNFa stimulation ( Figure 6A ).
This result suggests that IKK may prime BAD for its phosphorylation at the regulatory serines, thereby regulating BAD mitochondria translocation.
To determine whether inhibition of BAD mitochondria translocation by IKK indeed depends on priming BAD phosphorylation at the regulatory serines, Bad Although BAD(3SA) mutant could not be phosphorylated at the regulatory serines, it was still phosphorylated at Ser26 upon TNFa stimulation ( Figure 6B ). Under the same conditions, a small portion of BAD(3SA) mutant ($3%-7%), but not WT BAD, translocated to the mitochondria ( Figure 6C ). Importantly, a similar portion of Ser26-phosphorylated BAD(3SA) mutant ($3%-6%) also translocated to the mitochondria translocation ( Figure 6C ). Furthermore, apoptotic cell death was significantly increased in TNFa-treated Bad(3SA) + MEFs in comparison with Bad(WT) + MEFs ( Figure 6D ). Taken together, the inhibition of BAD mitochondria translocation and proapoptotic activity by IKK indeed depends on priming BAD phosphorylation at the regulatory serines.
To determine whether priming BAD phosphorylation at the regulatory serines by IKK is involved in suppression of TNFainduced apoptosis in vivo, we used WT and Bad 3SA/3SA knockin mice. Immunoblotting analysis revealed that the expression level of BAD(3SA) mutant was similar to that of endogenous BAD (Figure S5A) . When D-GalN-sensitized mice were injected intraperitoneally with TNFa, Bad 3SA/3SA knockin mice had accelerated and severe liver damage with massive hepatocyte apoptosis and mortality as compared to WT mice ( Figures S5B and 6E) . These results suggest that priming BAD phosphorylation by IKK at the regulatory serines is required for suppression of TNFa-induced apoptosis in vivo.
Phosphorylation of BAD at Ser26 by IKK Inhibits the Proapoptotic Activity of BAD
To determine the role of IKK-mediated Ser26 phosphorylation in regulation of BAD proapoptotic activity, we established Bad À/À stable cell lines expressing similar levels of WT M2-BAD or M2-BAD(S26A) mutant ( Figure S6A ). As expected, immunoblotting analysis revealed that ectopically expressed WT BAD, but not BAD(S26A) mutant, was phosphorylated at Ser26 upon TNFa stimulation ( Figure S6A ). In addition, TNFa induced phosphorylation of WT BAD, but not BAD(S26A) mutant at Ser112, Ser136, and Ser155 ( Figure S6A ). Furthermore, there were no detectable differences in TNFa-induced activation of IKK and NF-kB between Bad(WT) + and Bad(S26A) + MEFs, as measured by IkBa degradation and resynthesis ( Figure S6A ) and by the promoter activity of NF-kB by luciferase assays ( Figure S6B ). These results demonstrate that elimination of IKK-mediated Ser26-phosphorylation abrogates BAD phosphorylation at the regulatory serines without affecting IKK activity and NF-kB activation upon TNFa stimulation. Next, we determined whether IKK-mediated Ser26 phosphorylation of BAD is required for suppression of TNFa-induced apoptosis. TNFa induced apoptosis in both Bad(WT) + and
Bad(S26A)
+ MEFs when cells were infected with adenoviral vector encoding HA-IkBa(AA) ( Figure 7A ). However, like Ikkb (Figure 1C) . Similar results were obtained when Casp-3 activity or without TNFa (5 ng/ml) and fractionated as described in (A). 14-3-3-and BCL-X L -associated BAD or Ser26-phosphorylated BAD were analyzed by immunoprecipitation in combination with immunoblotting. BAD Ser26-phosphorylation, expression levels of BAD, 14-3-3, BCL-X L , b-actin, and COX-II were determined.
(D and E) WT, RelA À/À , and Ikkb À/À MEFs were stimulated with or without TNFa (5 ng/ml, 1 hr) and then separated into cytosol (D) and mitochondria (E) fractions. 14-3-3-and BCL-X L -associated BAD or Ser26-phosphorylated BAD, BAD Ser26-phosphorylation, expression levels of BAD, 14-3-3, BCL-X L , and COX-II were determined as described in (B) and (C). All data represent two to three individual experiments with similar results. See also Figure S4 .
was measured ( Figure 7C ). Under the same conditions, TNFa induced phosphorylation of the regulatory serine residues (Ser112, Ser136, and Ser155) in Bad(WT) + , but not in Bad(S26A) + MEFs ( Figure 7D ), suggesting that elimination of Ser26 phosphorylation promotes BAD proapoptotic activity. To determine whether IKK-mediated Ser26-phosphorylation of BAD is involved in TNFa-induced apoptosis in vivo, we used WT and Bad knockout mice that have been reconstituted with WT Bad or Bad(S26A) mutant via adenovirus infection. Immunoblotting analysis revealed that expression levels of reconstituted BAD were similar to that of endogenous BAD ( Figure S6C had accelerated and severe liver damage with massive apoptosis of hepatocytes ( Figure S6D ) and died within 10 hr ( Figure 7E ). Taken together, these results demonstrate that IKK-mediated Ser26-phosphorylation of BAD is required for suppression of TNFa-induced apoptosis in vivo.
DISCUSSION
It has long been thought that IKK inhibits TNFa-induced apoptosis through activation of NF-kB (Baldwin, 2012; Ghosh and Karin, 2002; Karin and Ben-Neriah, 2000; Karin and Lin, 2002; Liu and Lin, 2007) . Overwhelming evidence shows that IKKb is essential for TNFa to activate NF-kB, which in turn inhibits TNFa-induced apoptosis (Baldwin, 2012; Hoffmann and Baltimore, 2006; Karin and Lin, 2002; Liu and Lin, 2007) . Although several IKK substrates, including p53, FOXO3a, TSC-1, IRS-1, and Dok-1, are involved in cell survival related to allergy, immunity, and cancer (Baldwin, 2012) , their role in IKK-mediated inhibition of TNFa-induced apoptosis remains obscure. In this report, we demonstrate that phosphorylation and inactivation of BAD by (E) WT and Bad 3SA/3SA knockin mice were sensitized by D-GalN and then injected intraperitoneally with TNFa, as described in Figures 2E and 2F . Dying animals were premoved, and mortality rate was determined, p < 0.001; n = 6 (E), as analyzed by log rank (Mantel-Cox) test. See also Figure S5 .
IKK independently of NF-kB is required for suppressing TNFainduced apoptosis. Thus, IKK inhibits TNFa-induced apoptosis through at least two distinct mechanisms: activation of NF-kB and inhibition of BAD ( Figure 7F ). Our finding that TNFa via IKK inhibits the proapoptotic activity of BAD unmasks the involvement of a mitochondria-dependent death pathway in TNFa-induced apoptosis. TNFa-induced apoptosis is mainly mediated by the receptor-dependent death pathway (Baud and Karin, 2001 ). Our results show that BAD was involved in TNFa-induced apoptosis in various cultured cells (fibroblasts, CHO, FL83B, and primary thymocytes and hepatocytes) ( Figures 2D and S2C-S2E ) and in animals ( Figures 2E and  2F) . Thus, TNFa can induce apoptosis through both receptordependent death pathway and BAD-dependent mitochondrial death pathway.
IKK is a BAD kinase upon TNFa stimulation. The proapoptotic activity of BAD is inhibited by a variety of growth and survival factors, which induce BAD phosphorylation at the regulatory serines (Ser112, Ser136, and Ser155) and Thr201 (Danial and Korsmeyer, 2004; Danial, 2008; Dragovich et al., 1998; Liu and Lin, 2007; Youle and Strasser, 2008) . Our results show that, unlike known BAD kinases, IKK phosphorylated BAD at Ser26 residue in vitro and in vivo (Figures 3 and 4) . The phosphorylation most likely occurred in the cytoplasm, as both Ser26-phosphorylated BAD and IKKb exclusively resided in the cytoplasm in WT fibroblasts ( Figure 5A ), and only non-Ser26-phosphorylated BAD translocated to the mitochondria in Ikkb À/À MEFs ( Figure 5C ).
Thus, like survival factors, the inflammatory cytokine TNFa also inhibits BAD to suppress apoptosis. Phosphorylation by IKK at Ser26 primes BAD for inactivation. Previously, it has been reported that phosphorylation of Ser112 and Ser136 is required for phosphorylation of Ser155, although the mechanism is still not known (Danial, 2008) . Our results show that phosphorylation of BAD by IKK at Ser26 prevented BAD from translocating to the mitochondria ( Figure 5A ) by promoting the interaction between BAD with 14-3-3 ( Figure 5B ) and by suppressing the interaction between BAD with BCL-X L ( Figure 5C ). Because the surrounding amino acids of Ser26 (DPGIRpSLG) do not comprise the 14-3-3 binding motif (typically RSXpS/TXP or RXXXXpS/TXP; Yaffe, 2002) , IKK is most likely to regulate the association of BAD with 14-3-3 indirectly. In support of this notion, our data show that phosphorylation of BAD at the regulatory serines was impaired in Ikkb À/À MEFs ( Figure 6A ) and Bad À/À MEFs expressing BAD(S26A) mutant ( Figure S6A ). Thus, phosphorylation of BAD by IKK at Ser26 is a prerequisition for BAD to be further phosphorylated at the regulatory serines. The Ser26-phosphorylated BAD(3SA) mutant still translocated to the mitochondria to induce apoptosis in TNFa-treated Bad(3SA) + MEFs ( Figures 6B-6D ), suggesting that Ser26-phosphorylation indeed depends on phosphorylation of the regulatory serines to exert its function. The percentage of Ser26-phosphorylated BAD(3SA) mutant is similar to that of BAD(3SA) mutant ( Figure 6C ) or BAD ( Figure 5A ) that translocates to the mitochondria in the early time period after TNFa stimulation (%2 hr), indicating that phosphorylation of BAD by IKK at Ser26 plays a critical role in inhibiting the initiation of BAD mitochondrial translocation, thereby suppressing its proapoptotic activity. Future structural studies are needed to determine the mechanism underlying the priming effect of IKK-mediated Ser26 phosphorylation. The inhibition of BAD by IKK is independent of NF-kB. Overwhelming evidence shows that IKK inhibits TNFa-induced apoptosis through activation of NF-kB (Baldwin, 2012; Ghosh and Karin, 2002; Karin and Ben-Neriah, 2000; Karin and Lin, 2002; Liu and Lin, 2007) . Our results show that IKK directly phosphorylated BAD at Ser26, thereby inhibiting its proapoptotic activity upon TNFa stimulation (Figures 3, 4, 5, 6, and 7) . This inhibition is independent of NF-kB, as BAD was still phosphorylated at Ser26 by IKK and was sequestered in the cytosol of RelA À/À MEFs ( Figures 5D and 5E ). Conversely, elimination of IKK-mediated BAD phosphorylation had no significant effects on RelA activation ( Figures S6A and S6B ). Although we cannot formally exclude that other IKK substrates might also be involved in regulation of TNFa-induced apoptosis, inactivation of BAD is an NF-kB-independent axis of the IKK survival signaling in suppression of TNFa-induced apoptosis. Figure S6D ) and died significantly faster than Bad(WT) + mice ( Figure 7E ). Thus, phosphorylation of BAD at Ser26 by IKK is a physiologically relevant and important regulation. This conclusion is further supported by the observations that similar results were obtained in Bad 3SA/3SA knockin mice ( Figures 6D, 6E , and S5B). Our findings are also consistent with previous reports that Ikkb À/À mice died earlier (E13.5) (Li et al., 1999a (Li et al., , 1999b than RelA À/À mice (E15-E16) (Beg et al., 1995) . The inability of inactivating BAD in Ikkb À/À mice might account for their earlier embryonic lethality. Future studies are needed to explore this scenario.
Inactivation of BAD by IKK may work in coordination with activation of NF-kB to inhibit TNFa-induced apoptosis. As a key survival factor, NF-kB is essential for cell survival upon TNFa stimulation. However, NF-kB activation is a relatively slow process that involves IkBa phosphorylation, ubiquitination, and degradation; nuclear translocation of NF-kB dimmer; induction of NF-kB target genes; and synthesis of corresponding protein products (Ghosh and Karin, 2002; Karin and Ben-Neriah, 2000) . By contrast, inactivation of BAD by IKK is direct and rapid. Our results show that BAD was phosphorylated by IKK at Ser26 within minutes in TNFa-stimulated WT fibroblasts ( Figures 4F,  6A, and S4 ). In the absence of IKKb, BAD started to translocate to the mitochondria as early as 5 min after TNFa stimulation (Figure S4) . It is most likely that BAD may be involved in the initiation of TNFa-induced apoptosis. The rapid inactivation of BAD by IKK may be critical to protect cells from TNFa-induced apoptosis before IKK-activated NF-kB is able to induce inhibitors of apoptosis (IAPs) to suppress the apoptosis. Thus, the two parallel and independent signaling axes of IKK (i.e., activation of NF-kB and inhibition of BAD) may function in coordination in inhibition of TNFa-induced apoptosis ( Figure 7F ).
EXPERIMENTAL PROCEDURES Reagents
Antibodies against BAD, IkBa, PARP, phospho-IKKa/b, phospho-BAD(S112), phospho-BAD (S136), and phospho-BAD(S155) were from Cell Signaling. Antiphospho-BAD(S26) antibody was custom made by Abiocode Inc. using the synthetic phosphopeptide RKSDPGIRpSLGSD as the immunogen. Antibodies against COX-II, BCL-X L , IKKg, RelA, cRel, pan 14-3-3, and Casp-3 were from Santa Cruz. Antibody against IKKb was from Millipore. Anti-M2 antibody, the IKKb inhibitor PS-1145, and Hoechst were from Sigma. Propidium iodide (PI) and Annexin V were from BD PharMingen. D-Galactosamine Hydrochloride (D-GalN) was from MP Biomedicals. [ 32 P]ATP was from PerkinElmer. TNFa was from R&D (murine) or PeproTech (human). pcDNA3.1-Hygromycin(+) vectors encoding M2-BAD or M2-BAD(S26A) mutant were subcloned, as described previously (Yu et al., 2004) . S26A mutation and 3SA mutation were introduced using Quick-Change site-directed mutagenesis kit (Stratagene) and were verified by DNA sequencing. Expression vectors encoding HA-BCL-X L , GST-BAD, GST-c-Jun, GST-IkBa, GST-DN-BAD(115-204), and GST-DC-BAD(1-114) were described previously (Yu et al., 2004) . HA-IKKb, HA-IKKb(EE), and NF-kB luciferase reporter gene were gifts from Dr. Joseph A. DiDonato at Cleveland Clinic Foundation. IKKb(EE) protein, which had been purified to near homogeneity from baculovirus-encoding IKKb(EE)-infected sf9 cells, was a gift from Dr. Frank Muricio at Cellgene. The sequences of siRNA are siBAD: AGCUCCUGUUUGGAGUUUCAAA, siIKKb: CAGAA GAGCGAAGUGG ACAUCU, siRelA: GAGUUUCAGCAGCUCCUGAAC, and siCtrl: GGAGCGCACCAUCUUCUUC. The recombinant adenovirus encoding WT Bad, Bad(S26A), or Bad(3SA) mutant or the EGFP control were generated using standard procedures and were purified by CsCl density gradient centrifugation (Xiang et al., 2000) . Karin at University of California, San Diego. Bad À/À MEFs were described previously (Ranger et al., 2003) . FL83B cells were from ATCC. Cells were grown in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum, 2 mM glutamine, 100 U/ml penicillin, and 100 mg/ml streptomycin. To establish Bad À/À MEFs stably expressing WT BAD or BAD(S26A) mutant, Bad À/À MEFs were first transfected with pcDNA3.1-Puromycin(+)-HA-BCL-X L and selected with puromycin (1.5 mg/ml). Bad À/À MEFs stably expressing HA-BCL-X L were then transfected with pcDNA3.1-Hygromycin(+)-M2-BAD or -M2-BAD(S26A) and were further selected with hygromycin (100 mg/ml).
Animal Experiments
Bad À/À and Bad 3SA/3SA mice were described previously (Danial, 2008 
Statistical Analysis
The percentage of apoptotic cells among groups was determined using Student's t test. Mouse survival curves were constructed using the KaplanMeier product limit estimator and compared using the log rank (Mantel-Cox) test. p < 0.05 was considered to be significant in all experiments.
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